International Journal of Antimicrobial Agents
Volume 36, Issue 3 , Pages 239-242 , September 2010

Hypermutability in clinical isolates of Klebsiella pneumoniae is uncommon and is unrelated to ciprofloxacin resistance

  • S. Aathithan

      Affiliations

    • Corresponding Author InformationCorresponding author at: King's College London, Department of Infectious Diseases, Westminster Bridge Road, 5th Floor, North Wing, St. Thomas’ Hospital, London SE1 7EH, United Kingdom. Tel.: +44 207 188 3127; fax: +44 207 928 0730.
    • ,
  • G.L. French

Received 16 February 2010 ,Accepted 27 April 2010.

References 

  1. Bridges BA. Hypermutation in bacteria and other cellular systems. Philos Trans R Soc Lond B Biol Sci. 2001;356:29–39
  2. Chopra I, O’Neill AJ, Miller K. The role of mutators in the emergence of antibiotic-resistant bacteria. Drug Resist Updat. 2003;6:137–145
  3. Hall LMC, Henderson-Begg SK. Hypermutable bacteria isolated from humans—a critical analysis. Microbiology. 2006;152:2505–2514
  4. Oliver A, Canton R, Campo P, Baquero F, Blazquez J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science. 2000;288:1251–1253
  5. Modrich P. Methyl-directed DNA mismatch correction. J Biol Chem. 1989;264:6597–6600
  6. LeClerc JE, Li B, Payne WL, Cebula TA. High mutation frequencies among Escherichia coli and Salmonella pathogens. Science. 1996;274:1208–1211
  7. Blazquez J. Hypermutation as a factor contributing to the acquisition of antimicrobial resistance. Clin Infect Dis. 2003;37:1201–1209
  8. Barbosa TM, Levy SB. Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J Bacteriol. 2000;182:3467–3474
  9. Gutierrez O, Juan C, Perez JL, Oliver A. Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients. Antimicrob Agents Chemother. 2004;48:3573–3575
  10. Landman D, Bratu S, Kochar S, Panwar M, Trehan M, Doymaz M, et al. Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY. J Antimicrob Chemother. 2007;60:78–82
  11. Hooper DC. Mechanisms of quinolone resistance. In:  Hooper DC,  Rubinstein E editor. Quinolone antimicrobial agents. Washington, DC: ASM Press; 2003;p. 41–67
  12. Aathithan S. Mechanisms and genetics of ciprofloxacin resistance in Klebsiella pneumoniae. PhD Thesis. London, UK: University of London; 2008.
  13. Phillips I, Culebras E, Moreno F, Baquero F. Induction of the SOS response by new 4-quinolones. J Antimicrob Chemother. 1987;20:631–638
  14. Luo N, Sahin O, Lin J, Michel LO, Zhang Q. In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump. Antimicrob Agents Chemother. 2003;47:390–394
  15. Maciá MD, Borrell N, Perez JL, Oliver A. Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion. Antimicrob Agents Chemother. 2004;48:2665–2672

☆ Part of this study was presented at the 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 16–19 May 2009, Helsinki, Finland (abstract P1481).

PII: S0924-8579(10)00198-6

doi: 10.1016/j.ijantimicag.2010.04.010

International Journal of Antimicrobial Agents
Volume 36, Issue 3 , Pages 239-242 , September 2010

Article Tools

* Image Usage & Resolution